← FDA Drug Approvals (Drugs@FDA)

NAMENDA XR

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2010-06-21

Drug application

FDA Application #

NDA022525

Application type

New Drug Application

Brand name

NAMENDA XR

Generic name

Memantine Hydrochloride

Active ingredients

MEMANTINE HYDROCHLORIDE

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

ABBVIE

First approval

2010-06-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown